Medicare will cover new class of Alzheimer’s drugs if fully approved by FDA, with limits
Jun 02, 2023
Drug makers also will have to gather and keep data in a registry showing how the drugs are working in the real world.
CMS announces Alzheimer’s drug coverage policy, but ‘the devil is in the details,’ experts say
By
Kimberly Bonvissuto
Jun 01, 2023
A Thursday announcement by the Centers for Medicare & Medicaid Services regarding coverage of Alzheimer’s drugs is being met with skepticism by some industry advocates who say that “the devil is in...
$14.6 million study, a first, aims to combat dementia in Native, Pacific Islander communities
By
Kimberly Bonvissuto
May 24, 2023
A first-ever study will adapt Alzheimer’s tests for Indigenous communities to expand treatment and research options for dementia in those populations.
FDA approves first drug meant to ease Alzheimer’s disease-llnked agitation
May 11, 2023
Patients who received 2 or 3 mg of Rexulti had significant improvements in agitation scores compared with patients taking a placebo.
$215,000 disability discrimination complaint could have ‘broader ramifications’ on resident contracts,...
By
Kimberly Bonvissuto
Apr 12, 2023
A Pennsylvania continuing care retirement community agreed to a $215,000 Fair Housing Act settlement over allegations of disability discrimination, but the senior living owners and operators said that...
US sets up $300 million database for Alzheimer’s disease research
Apr 05, 2023
In creating the database, the goal is to provide something that can “improve applicability and generalizability of findings.”
AI model using health records predicts Alzheimer’s disease up to 5 years before diagnosis
By
Kimberly Bonvissuto
Mar 01, 2023
A team of researchers designed an artificial intelligence system that can predict which individuals will develop Alzheimer’s disease up to five years before a diagnosis.
More news for Thursday, Feb. 23
By
Kimberly Bonvissuto
Feb 23, 2023
Idaho bill criminalizes administration of mRNA vaccines … Digital transformation improves productivity at CCRC … Assisted living community sued over drowning death of 93-year-old resident … $10K...
Bipartisan group pushes CMS to expand coverage for Alzheimer’s treatments
By
Kimberly Bonvissuto
Feb 21, 2023
Access to federally approved monoclonal antibody and other disease-modifying therapies for Alzheimer’s disease will be “extremely limited” unless the Centers for Medicare & Medicaid Services reconsiders...
Focus on briefs: Dementia
Feb 01, 2023
Alzheimer’s blood test, Aducanumab approval issues, Medicare coverage of brain scans that diagnose dementia, Some at higher risk for Alzheimer’s